What happens when your patient uses cannabinoid compounds for pain, especially if there are currently taking opioids? Just in time for Pain Awareness Month, the results from these new studies provide insights and guidance.
Substance Use Disorder
A recent report provides a global update on the growth of drug use and its consequences.
The cannabinoids (particularly CBD) have been hailed as non-addictive solutions to using escalating doses of opioids for chronic pain. More in this research update.
An interplay between genetic and early environmental factors contributes to the development of substance abuse.
New findings on a not-so-new epidemic have two key implications for psychiatrists.
Medical professionals don’t want to prescribe too many pain killers, which may contribute to the epidemic of opioid misuse, yet they don’t want patients to needlessly suffer.
James L. Knoll IV, MD, analyzes the ethical and legal duties of psychiatrists treating substance use disorders.
The costs, risks, and considerations involved in treating addiction have upped the ante, as illustrated in this case.
Cocaine, psychostimulant, and opioid deaths continue to climb, and polysubstance opioid overdose deaths outnumber opioid-only deaths—these and other reports headline the latest developments.
How many of us, during clinical encounters with patients, focus on their families, their social communities, their sources of human contact and support?